Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2229072
Max Phase: Preclinical
Molecular Formula: C21H22F3N9O2S
Molecular Weight: 521.53
Molecule Type: Small molecule
Associated Items:
ID: ALA2229072
Max Phase: Preclinical
Molecular Formula: C21H22F3N9O2S
Molecular Weight: 521.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(C)nc(N2CCN(Cn3nc(C(F)(F)F)n(/N=C/c4ccccc4[N+](=O)[O-])c3=S)CC2)n1
Standard InChI: InChI=1S/C21H22F3N9O2S/c1-14-11-15(2)27-19(26-14)30-9-7-29(8-10-30)13-31-20(36)32(18(28-31)21(22,23)24)25-12-16-5-3-4-6-17(16)33(34)35/h3-6,11-12H,7-10,13H2,1-2H3/b25-12+
Standard InChI Key: NFMXPRDFVPTQNC-BRJLIKDPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 521.53 | Molecular Weight (Monoisotopic): 521.1569 | AlogP: 3.41 | #Rotatable Bonds: 6 |
Polar Surface Area: 110.51 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 4.34 | CX LogP: 4.65 | CX LogD: 4.65 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.21 | Np Likeness Score: -2.17 |
1. Wang BL, Shi YX, Ma Y, Liu XH, Li YH, Song HB, Li BJ, Li ZM.. (2010) Synthesis and biological activity of some novel trifluoromethyl-substituted 1,2,4-triazole and bis(1,2,4-triazole) Mannich bases containing piperazine rings., 58 (9): [PMID:20384340] [10.1021/jf100300a] |
Source(1):